Vision and Vision-Related Measures in Progressive Multiple Sclerosis

Over the last few years there has been growing interest in use of visual measures as useful tools for multiple sclerosis (MS) prognosis and tracking. Optic neuritis (ON) being a prevalent and often-presenting symptom of the disease, as well as the high occurrence rate of posterior visual system dama...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Frontiers in Neurology Ročník 10; s. 455
Hlavní autori: Backner, Yael, Petrou, Panayiota, Glick-Shames, Haya, Raz, Noa, Zimmermann, Hanna, Jost, Rebecca, Scheel, Michael, Paul, Friedemann, Karussis, Dimitrios, Levin, Netta
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Switzerland Frontiers Media SA 03.05.2019
Frontiers Media S.A
Predmet:
ISSN:1664-2295, 1664-2295
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Over the last few years there has been growing interest in use of visual measures as useful tools for multiple sclerosis (MS) prognosis and tracking. Optic neuritis (ON) being a prevalent and often-presenting symptom of the disease, as well as the high occurrence rate of posterior visual system damage independent of ON (optic radiation lesions), make the visual system a prime candidate for such endeavors. However, while the visual system makes for a convenient model in early stages of MS, processes which may be true in those stages may drastically change as the disease progresses, due to accumulated disease load. Here, we examine whether vision-related tools reflect demyelinative and axonal damage of the visual pathways and may be used for assessment in the clinical setup in progressive multiple sclerosis (MS) patients, in whom disease load may alter the early stage picture. Forty-eight progressive MS patients, with and without prior optic neuritis (ON), underwent a battery of behavioral tests, visual evoked potential (VEP) tests, optical coherence tomography (OCT), and structural MRI scans, at two time-points. Data were analyzed for stability between visits and for correlation between behavioral and electrophysiological data. All measures were stable between visits. Significant differences were found in all measures between the affected and fellow eyes of ON patients and in VEP latencies between the affected and non-ON eyes. Motion perception differentially correlated with latencies of both ON eyes and with the non-ON eyes. Retinal nerve fiber layer thickness correlated with the latencies of non-ON eyes but not of either ON eye. No difference in lesion load was found between the ON and non-ON patients. ON still leaves its mark in the patient's visual system over time, with all visual measures of the affected eyes notably reduced compared to fellow eyes. Motion perception, reflecting myelination level along the visual pathway, shows its usefulness also in progressive MS. In the non-ON eyes, axonal loss appears to explain prolonged latencies, unlike in ON eyes, where demyelination appears to be the main mechanism. Lastly, the visual measures assessed herein are applicable as valid assessment tools in therapeutic studies.
AbstractList Background: Over the last few years there has been growing interest in use of visual measures as useful tools for multiple sclerosis (MS) prognosis and tracking. Optic neuritis (ON) being a prevalent and often-presenting symptom of the disease, as well as the high occurrence rate of posterior visual system damage independent of ON (optic radiation lesions), make the visual system a prime candidate for such endeavors. However, while the visual system makes for a convenient model in early stages of MS, processes which may be true in those stages may drastically change as the disease progresses, due to accumulated disease load. Here, we examine whether vision-related tools reflect demyelinative and axonal damage of the visual pathways and may be used for assessment in the clinical setup in progressive multiple sclerosis (MS) patients, in whom disease load may alter the early stage picture. Methods: Forty-eight progressive MS patients, with and without prior optic neuritis (ON), underwent a battery of behavioral tests, visual evoked potential (VEP) tests, optical coherence tomography (OCT), and structural MRI scans, at two time-points. Data were analyzed for stability between visits and for correlation between behavioral and electrophysiological data. Results: All measures were stable between visits. Significant differences were found in all measures between the affected and fellow eyes of ON patients and in VEP latencies between the affected and non-ON eyes. Motion perception differentially correlated with latencies of both ON eyes and with the non-ON eyes. Retinal nerve fiber layer thickness correlated with the latencies of non-ON eyes but not of either ON eye. No difference in lesion load was found between the ON and non-ON patients. Conclusions: ON still leaves its mark in the patient's visual system over time, with all visual measures of the affected eyes notably reduced compared to fellow eyes. Motion perception, reflecting myelination level along the visual pathway, shows its usefulness also in progressive MS. In the non-ON eyes, axonal loss appears to explain prolonged latencies, unlike in ON eyes, where demyelination appears to be the main mechanism. Lastly, the visual measures assessed herein are applicable as valid assessment tools in therapeutic studies.Background: Over the last few years there has been growing interest in use of visual measures as useful tools for multiple sclerosis (MS) prognosis and tracking. Optic neuritis (ON) being a prevalent and often-presenting symptom of the disease, as well as the high occurrence rate of posterior visual system damage independent of ON (optic radiation lesions), make the visual system a prime candidate for such endeavors. However, while the visual system makes for a convenient model in early stages of MS, processes which may be true in those stages may drastically change as the disease progresses, due to accumulated disease load. Here, we examine whether vision-related tools reflect demyelinative and axonal damage of the visual pathways and may be used for assessment in the clinical setup in progressive multiple sclerosis (MS) patients, in whom disease load may alter the early stage picture. Methods: Forty-eight progressive MS patients, with and without prior optic neuritis (ON), underwent a battery of behavioral tests, visual evoked potential (VEP) tests, optical coherence tomography (OCT), and structural MRI scans, at two time-points. Data were analyzed for stability between visits and for correlation between behavioral and electrophysiological data. Results: All measures were stable between visits. Significant differences were found in all measures between the affected and fellow eyes of ON patients and in VEP latencies between the affected and non-ON eyes. Motion perception differentially correlated with latencies of both ON eyes and with the non-ON eyes. Retinal nerve fiber layer thickness correlated with the latencies of non-ON eyes but not of either ON eye. No difference in lesion load was found between the ON and non-ON patients. Conclusions: ON still leaves its mark in the patient's visual system over time, with all visual measures of the affected eyes notably reduced compared to fellow eyes. Motion perception, reflecting myelination level along the visual pathway, shows its usefulness also in progressive MS. In the non-ON eyes, axonal loss appears to explain prolonged latencies, unlike in ON eyes, where demyelination appears to be the main mechanism. Lastly, the visual measures assessed herein are applicable as valid assessment tools in therapeutic studies.
Background: Over the last few years there has been growing interest in use of visual measures as useful tools for multiple sclerosis (MS) prognosis and tracking. Optic neuritis (ON) being a prevalent and often-presenting symptom of the disease, as well as the high occurrence rate of posterior visual system damage independent of ON (optic radiation lesions), make the visual system a prime candidate for such endeavors. However, while the visual system makes for a convenient model in early stages of MS, processes which may be true in those stages may drastically change as the disease progresses, due to accumulated disease load. Here, we examine whether vision-related tools reflect demyelinative and axonal damage of the visual pathways and may be used for assessment in the clinical setup in progressive multiple sclerosis (MS) patients, in whom disease load may alter the early stage picture.Methods: Forty-eight progressive MS patients, with and without prior optic neuritis (ON), underwent a battery of behavioral tests, visual evoked potential (VEP) tests, optical coherence tomography (OCT), and structural MRI scans, at two time-points. Data were analyzed for stability between visits and for correlation between behavioral and electrophysiological data.Results: All measures were stable between visits. Significant differences were found in all measures between the affected and fellow eyes of ON patients and in VEP latencies between the affected and non-ON eyes. Motion perception differentially correlated with latencies of both ON eyes and with the non-ON eyes. Retinal nerve fiber layer thickness correlated with the latencies of non-ON eyes but not of either ON eye. No difference in lesion load was found between the ON and non-ON patients.Conclusions: ON still leaves its mark in the patient's visual system over time, with all visual measures of the affected eyes notably reduced compared to fellow eyes. Motion perception, reflecting myelination level along the visual pathway, shows its usefulness also in progressive MS. In the non-ON eyes, axonal loss appears to explain prolonged latencies, unlike in ON eyes, where demyelination appears to be the main mechanism. Lastly, the visual measures assessed herein are applicable as valid assessment tools in therapeutic studies.
Over the last few years there has been growing interest in use of visual measures as useful tools for multiple sclerosis (MS) prognosis and tracking. Optic neuritis (ON) being a prevalent and often-presenting symptom of the disease, as well as the high occurrence rate of posterior visual system damage independent of ON (optic radiation lesions), make the visual system a prime candidate for such endeavors. However, while the visual system makes for a convenient model in early stages of MS, processes which may be true in those stages may drastically change as the disease progresses, due to accumulated disease load. Here, we examine whether vision-related tools reflect demyelinative and axonal damage of the visual pathways and may be used for assessment in the clinical setup in progressive multiple sclerosis (MS) patients, in whom disease load may alter the early stage picture. Forty-eight progressive MS patients, with and without prior optic neuritis (ON), underwent a battery of behavioral tests, visual evoked potential (VEP) tests, optical coherence tomography (OCT), and structural MRI scans, at two time-points. Data were analyzed for stability between visits and for correlation between behavioral and electrophysiological data. All measures were stable between visits. Significant differences were found in all measures between the affected and fellow eyes of ON patients and in VEP latencies between the affected and non-ON eyes. Motion perception differentially correlated with latencies of both ON eyes and with the non-ON eyes. Retinal nerve fiber layer thickness correlated with the latencies of non-ON eyes but not of either ON eye. No difference in lesion load was found between the ON and non-ON patients. ON still leaves its mark in the patient's visual system over time, with all visual measures of the affected eyes notably reduced compared to fellow eyes. Motion perception, reflecting myelination level along the visual pathway, shows its usefulness also in progressive MS. In the non-ON eyes, axonal loss appears to explain prolonged latencies, unlike in ON eyes, where demyelination appears to be the main mechanism. Lastly, the visual measures assessed herein are applicable as valid assessment tools in therapeutic studies.
Author Dimitrios Karussis
Michael Scheel
Rebecca Jost
Netta Levin
Yael Backner
Friedemann Paul
Panayiota Petrou
Noa Raz
Hanna Zimmermann
Haya Glick-Shames
AuthorAffiliation 1 fMRI Unit, Neurology Department, Hadassah-Hebrew University Medical Center , Jerusalem , Israel
3 NeuroCure Clinical Research Center, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health , Berlin , Germany
4 Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité-Universitätsmedizin Berlin , Berlin , Germany
2 Neurology Department, The Multiple Sclerosis Center, Hadassah-Hebrew University Medical Center , Jerusalem , Israel
AuthorAffiliation_xml – name: 3 NeuroCure Clinical Research Center, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health , Berlin , Germany
– name: 1 fMRI Unit, Neurology Department, Hadassah-Hebrew University Medical Center , Jerusalem , Israel
– name: 4 Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité-Universitätsmedizin Berlin , Berlin , Germany
– name: 2 Neurology Department, The Multiple Sclerosis Center, Hadassah-Hebrew University Medical Center , Jerusalem , Israel
Author_xml – sequence: 1
  givenname: Yael
  surname: Backner
  fullname: Backner, Yael
– sequence: 2
  givenname: Panayiota
  surname: Petrou
  fullname: Petrou, Panayiota
– sequence: 3
  givenname: Haya
  surname: Glick-Shames
  fullname: Glick-Shames, Haya
– sequence: 4
  givenname: Noa
  surname: Raz
  fullname: Raz, Noa
– sequence: 5
  givenname: Hanna
  surname: Zimmermann
  fullname: Zimmermann, Hanna
– sequence: 6
  givenname: Rebecca
  surname: Jost
  fullname: Jost, Rebecca
– sequence: 7
  givenname: Michael
  surname: Scheel
  fullname: Scheel, Michael
– sequence: 8
  givenname: Friedemann
  surname: Paul
  fullname: Paul, Friedemann
– sequence: 9
  givenname: Dimitrios
  surname: Karussis
  fullname: Karussis, Dimitrios
– sequence: 10
  givenname: Netta
  surname: Levin
  fullname: Levin, Netta
BackLink https://cir.nii.ac.jp/crid/1872835443063001728$$DView record in CiNii
https://www.ncbi.nlm.nih.gov/pubmed/31130910$$D View this record in MEDLINE/PubMed
BookMark eNp9UUtv1DAYtFARLUvvnFAOHLhk8Tv2BQmVV6VWIF5Xy46_LK6y9tZOKvHvcXZb1HIgsuKx_c2M_c1TdBRTBISeE7xmTOnXQ4Q5rykmeo0xF-IROiFS8pZSLY7u4WN0WsoVrh_Tmkn2BB0zQhjWBJ-gdz9DCSk2NvrmANuvMNoJfHMJtswZShNi8yWnTYUl3EBzOY9T2I3QfOtHyKmE8gw9HuxY4PR2XqEfH95_P_vUXnz-eH729qLtheim1npPhXdeW6c5xpYtz1CaAvGiG1gdGntnCaYDAYEVGyj4Cq2yTnXKsRU6P-j6ZK_MLoetzb9NssHsN1LeGJunUK9lNJcOKFXSKcm507pzFpjDouvJ4Kr3Cr05aO1mtwXfQ5yyHR-IPjyJ4ZfZpBsjRe0cV1Xg1a1ATtczlMlsQ-lhHG2ENBdDKaOEckmW0hf3vf6a3MVQC-ShoK_9LBkG04fJTjWNah1GQ7BZemX2kZslcrOPvBLxP8Q77f9QXh4oMYRqs_yJ6qhignOGJcOYLKs_x0S6HQ
CitedBy_id crossref_primary_10_1016_j_clinph_2024_02_020
crossref_primary_10_1007_s00415_021_10561_2
crossref_primary_10_1016_j_msard_2022_104116
crossref_primary_10_3390_s20010007
crossref_primary_10_1038_s41582_024_01006_1
crossref_primary_10_3389_fnins_2021_692599
crossref_primary_10_4103_njcp_njcp_1568_21
crossref_primary_10_1016_j_msard_2021_103349
crossref_primary_10_1177_13524585211032801
crossref_primary_10_25259_SNI_719_2024
crossref_primary_10_7759_cureus_56094
crossref_primary_10_1016_j_neuroimage_2020_117204
crossref_primary_10_1007_s00415_023_12075_5
crossref_primary_10_1007_s00415_024_12803_5
crossref_primary_10_3389_fnmol_2023_1125115
crossref_primary_10_1016_j_clinph_2022_02_013
crossref_primary_10_3390_jcm11102936
crossref_primary_10_1002_hbm_25744
crossref_primary_10_3390_cells10061507
crossref_primary_10_3389_fneur_2020_00450
Cites_doi 10.1007/s13167-017-0102-x
10.1177/1352458516649677
10.1177/1352458514538110
10.3109/02713683.2015.1119283
10.1002/ana.22005
10.1006/nimg.2002.1040
10.1016/j.jns.2015.07.037
10.1038/nrneurol.2014.108
10.1371/journal.pone.0102546
10.1016/S1474-4422(17)30278-8
10.18240/ijo.2018.02.24
10.1016/j.neuroimage.2004.07.051
10.1002/ana.22692
10.1016/j.neuroimage.2011.11.032
10.1016/j.neuroimage.2007.09.031
10.1212/WNL.0b013e3182a1aa3e
10.1177/1352458511431076
10.1097/WNO.0000000000000634
10.1016/S1474-4422(13)70259-X
10.1136/bmj.4.5893.661
10.1196/annals.1379.009
10.1212/NXI.0000000000000449
10.1007/s00330-014-3358-8
10.1212/WNL.0b013e31821f4602
10.1002/ana.22366
10.1212/WNL.0000000000000522
10.1212/NXI.0000000000000135
10.1093/brain/awu335
10.1001/jamaneurol.2017.3880
10.1016/j.ophtha.2007.08.004
10.1002/ana.20851
ContentType Journal Article
Copyright Copyright © 2019 Backner, Petrou, Glick-Shames, Raz, Zimmermann, Jost, Scheel, Paul, Karussis and Levin. 2019 Backner, Petrou, Glick-Shames, Raz, Zimmermann, Jost, Scheel, Paul, Karussis and Levin
Copyright_xml – notice: Copyright © 2019 Backner, Petrou, Glick-Shames, Raz, Zimmermann, Jost, Scheel, Paul, Karussis and Levin. 2019 Backner, Petrou, Glick-Shames, Raz, Zimmermann, Jost, Scheel, Paul, Karussis and Levin
DBID RYH
AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.3389/fneur.2019.00455
DatabaseName CiNii Complete
CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

PubMed

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1664-2295
ExternalDocumentID oai_doaj_org_article_946be2286b8644b997bae3b057c1fb0a
PMC6509148
31130910
10_3389_fneur_2019_00455
Genre Journal Article
GrantInformation_xml – fundername: National Multiple Sclerosis Society
  grantid: 5128-A-1
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
ACGFO
ACGFS
ADBBV
ADRAZ
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
DIK
E3Z
EMOBN
F5P
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
O5R
O5S
OK1
P2P
PGMZT
RNS
RPM
RYH
AAYXX
CITATION
ACXDI
IAO
IEA
IHR
IHW
IPNFZ
NPM
RIG
7X8
5PM
ID FETCH-LOGICAL-c557t-add25dbd9ab9400a33389892e1d57f37f390dba102f1e5083f2edf1ea8ab878b3
IEDL.DBID DOA
ISICitedReferencesCount 19
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000467343600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1664-2295
IngestDate Fri Oct 03 12:40:56 EDT 2025
Tue Sep 30 15:40:07 EDT 2025
Thu Sep 04 20:22:06 EDT 2025
Thu Jan 02 23:03:13 EST 2025
Tue Nov 18 21:38:43 EST 2025
Sat Nov 29 05:07:59 EST 2025
Mon Nov 10 09:14:11 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords VEP
OCT
fellow eye
motion perception
multiple sclerosis
optic neuritis
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c557t-add25dbd9ab9400a33389892e1d57f37f390dba102f1e5083f2edf1ea8ab878b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Letizia Leocani, San Raffaele Hospital (IRCCS), Italy
This article was submitted to Multiple Sclerosis and Neuroimmunology, a section of the journal Frontiers in Neurology
Reviewed by: Edgar Carnero Contentti, Hospital Alemán, Argentina; Izumi Kawachi, Niigata University, Japan
ORCID 0000-0002-3505-2914
0000-0002-6378-0070
0000-0002-0276-8051
OpenAccessLink https://doaj.org/article/946be2286b8644b997bae3b057c1fb0a
PMID 31130910
PQID 2232124618
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_946be2286b8644b997bae3b057c1fb0a
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6509148
proquest_miscellaneous_2232124618
pubmed_primary_31130910
crossref_citationtrail_10_3389_fneur_2019_00455
crossref_primary_10_3389_fneur_2019_00455
nii_cinii_1872835443063001728
PublicationCentury 2000
PublicationDate 2019-05-03
PublicationDateYYYYMMDD 2019-05-03
PublicationDate_xml – month: 05
  year: 2019
  text: 2019-05-03
  day: 03
PublicationDecade 2010
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in Neurology
PublicationTitleAlternate Front Neurol
PublicationYear 2019
Publisher Frontiers Media SA
Frontiers Media S.A
Publisher_xml – name: Frontiers Media SA
– name: Frontiers Media S.A
References Polman (B12) 2011; 69
Langdon (B13) 2012; 18
Oberwahrenbrock (B8) 2018; 5
Raz (B4) 2011; 76
Petzold (B7) 2017; 16
Smith (B17) 2002; 17
Talman (B6) 2010; 67
Klistorner (B28) 2014; 82
Raz (B20) 2012; 71
Halliday (B23) 1973; 4
Raz (B24) 2013; 81
Group (B22) 2008; 115
Backner (B32) 2018; 38
Backner (B10) 2018; 75
Alshowaeir (B27) 2018; 11
Schippling (B15) 2015; 21
Petzold (B1) 2014; 10
Sriram (B30) 2014; 9
Galetta (B2) 2015; 2
(B21) 1988; 2
Esen (B31) 2016; 41
Smith (B18) 2004; 23
Shattuck (B19) 2008; 39
Sinnecker (B29) 2015; 25
Benoliel (B25) 2016; 23
Toosy (B11) 2014; 13
Balcer (B3) 2014; 138
Raz (B14) 2015; 357
Schmidt (B16) 2012; 59
Costello (B5) 2006; 59
Sperling (B26) 2007; 1097
Kuchling (B9) 2017; 8
References_xml – volume: 8
  start-page: 279
  year: 2017
  ident: B9
  article-title: Diffusion tensor imaging for multilevel assessment of the visual pathway: possibilities for personalized outcome prediction in autoimmune disorders of the central nervous system
  publication-title: EPMA J.
  doi: 10.1007/s13167-017-0102-x
– volume: 23
  start-page: 220
  year: 2016
  ident: B25
  article-title: Cortical functional modifications following optic neuritis
  publication-title: Mult Scler.
  doi: 10.1177/1352458516649677
– volume: 21
  start-page: 163
  year: 2015
  ident: B15
  article-title: Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria
  publication-title: Multiple Scler J.
  doi: 10.1177/1352458514538110
– volume: 41
  start-page: 1353
  year: 2016
  ident: B31
  article-title: Evaluation of the innermost retinal layers and visual evoked potentials in patients with multiple sclerosis
  publication-title: Curr Eye Res.
  doi: 10.3109/02713683.2015.1119283
– volume: 67
  start-page: 749
  year: 2010
  ident: B6
  article-title: Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis
  publication-title: Ann Neurol.
  doi: 10.1002/ana.22005
– volume: 17
  start-page: 479
  year: 2002
  ident: B17
  article-title: Accurate, robust, and automated longitudinal and cross-sectional brain change analysis
  publication-title: Neuroimage.
  doi: 10.1006/nimg.2002.1040
– volume: 357
  start-page: 235
  year: 2015
  ident: B14
  article-title: Temporal aspects of visual perception in demyelinative diseases
  publication-title: J Neurol Sci.
  doi: 10.1016/j.jns.2015.07.037
– volume: 10
  start-page: 447
  year: 2014
  ident: B1
  article-title: The investigation of acute optic neuritis: a review and proposed protocol
  publication-title: Nat Rev Neurol.
  doi: 10.1038/nrneurol.2014.108
– volume: 9
  start-page: e102546
  year: 2014
  ident: B30
  article-title: Relationship between optical coherence tomography and electrophysiology of the visual pathway in non-optic neuritis eyes of multiple sclerosis patients
  publication-title: PLoS ONE.
  doi: 10.1371/journal.pone.0102546
– volume: 16
  start-page: 797
  year: 2017
  ident: B7
  article-title: Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis
  publication-title: Lancet Neurol.
  doi: 10.1016/S1474-4422(17)30278-8
– volume: 11
  start-page: 329
  year: 2018
  ident: B27
  article-title: Mechanism of delayed conduction of fellow eyes in patients with optic neuritis
  publication-title: Int J Ophthalmol.
  doi: 10.18240/ijo.2018.02.24
– volume: 23
  start-page: S208
  year: 2004
  ident: B18
  article-title: Advances in functional and structural MR image analysis and implementation as FSL
  publication-title: Neuroimage.
  doi: 10.1016/j.neuroimage.2004.07.051
– volume: 71
  start-page: 531
  year: 2012
  ident: B20
  article-title: Demyelination affects temporal aspects of perception: an optic neuritis study
  publication-title: Ann Neurol.
  doi: 10.1002/ana.22692
– volume: 59
  start-page: 3774
  year: 2012
  ident: B16
  article-title: An automated tool for detection of FLAIR-hyperintense white-matter lesions in multiple sclerosis
  publication-title: Neuroimage.
  doi: 10.1016/j.neuroimage.2011.11.032
– volume: 39
  start-page: 1064
  year: 2008
  ident: B19
  article-title: Construction of a 3D probabilistic atlas of human cortical structures
  publication-title: Neuroimage.
  doi: 10.1016/j.neuroimage.2007.09.031
– volume: 81
  start-page: 702
  year: 2013
  ident: B24
  article-title: Temporal reorganization to overcome monocular demyelination
  publication-title: Neurology.
  doi: 10.1212/WNL.0b013e3182a1aa3e
– volume: 18
  start-page: 891
  year: 2012
  ident: B13
  article-title: Recommendations for a brief international cognitive assessment for multiple sclerosis (BICAMS)
  publication-title: Multiple Sclerosis J.
  doi: 10.1177/1352458511431076
– volume: 38
  start-page: 85
  year: 2018
  ident: B32
  article-title: Keep your eyes wide open: on visual-and vision-related measurements to better understand multiple sclerosis pathophysiology
  publication-title: J Neuro-Ophthalmol.
  doi: 10.1097/WNO.0000000000000634
– volume: 13
  start-page: 83
  year: 2014
  ident: B11
  article-title: Optic neuritis
  publication-title: Lancet Neurol.
  doi: 10.1016/S1474-4422(13)70259-X
– volume: 4
  start-page: 661
  year: 1973
  ident: B23
  article-title: Visual evoked response in diagnosis of multiple sclerosis
  publication-title: Br Med J.
  doi: 10.1136/bmj.4.5893.661
– volume: 1097
  start-page: 146
  year: 2007
  ident: B26
  article-title: Functional MRI studies of associative encoding in normal aging, mild cognitive impairment, and Alzheimer's disease
  publication-title: Ann N Y Acad Sci.
  doi: 10.1196/annals.1379.009
– volume: 5
  start-page: e449
  year: 2018
  ident: B8
  article-title: Multicenter reliability of semiautomatic retinal layer segmentation using OCT
  publication-title: Neurol Neuroimmunol Neuroinflamm.
  doi: 10.1212/NXI.0000000000000449
– volume: 25
  start-page: 122
  year: 2015
  ident: B29
  article-title: Optic radiation damage in multiple sclerosis is associated with visual dysfunction and retinal thinning-an ultrahigh-field MR pilot study
  publication-title: Eur Radiol.
  doi: 10.1007/s00330-014-3358-8
– volume: 76
  start-page: 2103
  year: 2011
  ident: B4
  article-title: Sustained motion perception deficit following optic neuritis behavioral and cortical evidence
  publication-title: Neurology.
  doi: 10.1212/WNL.0b013e31821f4602
– volume: 69
  start-page: 292
  year: 2011
  ident: B12
  article-title: Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
  publication-title: Ann Neurol.
  doi: 10.1002/ana.22366
– volume: 82
  start-page: 2165
  year: 2014
  ident: B28
  article-title: Axonal loss of retinal neurons in multiple sclerosis associated with optic radiation lesions
  publication-title: Neurology.
  doi: 10.1212/WNL.0000000000000522
– volume: 2
  start-page: e135
  year: 2015
  ident: B2
  article-title: Acute optic neuritis Unmet clinical needs and model for new therapies
  publication-title: Neurol Neuroimmunol Neuroinflamm.
  doi: 10.1212/NXI.0000000000000135
– volume: 138
  start-page: 11
  year: 2014
  ident: B3
  article-title: Vision and vision-related outcome measures in multiple sclerosis
  publication-title: Brain.
  doi: 10.1093/brain/awu335
– volume: 75
  start-page: 287
  year: 2018
  ident: B10
  article-title: Anatomical wiring and functional networking changes in the visual system following optic neuritis
  publication-title: JAMA Neurol.
  doi: 10.1001/jamaneurol.2017.3880
– volume: 115
  start-page: e1075
  year: 2008
  ident: B22
  article-title: Visual function 15 years after optic neuritis: a final follow-up report from the optic neuritis treatment trial
  publication-title: Ophthalmology.
  doi: 10.1016/j.ophtha.2007.08.004
– volume: 2
  start-page: 1
  year: 1988
  ident: B21
  article-title: Visual acuity measurement standard
  publication-title: Italian J Ophthalmol.
– volume: 59
  start-page: 963
  year: 2006
  ident: B5
  article-title: Quantifying axonal loss after optic neuritis with optical coherence tomography
  publication-title: Ann Neurol.
  doi: 10.1002/ana.20851
SSID ssj0000399363
Score 2.2691116
Snippet Over the last few years there has been growing interest in use of visual measures as useful tools for multiple sclerosis (MS) prognosis and tracking. Optic...
Background: Over the last few years there has been growing interest in use of visual measures as useful tools for multiple sclerosis (MS) prognosis and...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
nii
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 455
SubjectTerms fellow eye
Function and Dysfunction of the Nervous System
motion perception
multiple sclerosis
Neurology
Neurology. Diseases of the nervous system
OCT
optic neuritis
RC346-429
VEP
Title Vision and Vision-Related Measures in Progressive Multiple Sclerosis
URI https://cir.nii.ac.jp/crid/1872835443063001728
https://www.ncbi.nlm.nih.gov/pubmed/31130910
https://www.proquest.com/docview/2232124618
https://pubmed.ncbi.nlm.nih.gov/PMC6509148
https://doaj.org/article/946be2286b8644b997bae3b057c1fb0a
Volume 10
WOSCitedRecordID wos000467343600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1664-2295
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000399363
  issn: 1664-2295
  databaseCode: DOA
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1664-2295
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000399363
  issn: 1664-2295
  databaseCode: M~E
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1NT9wwEB21CFW9VAX6kRaQK3HpIdqNncT2sS0gLouQWtDeLDu21UhVQOzCsb-9M3ZY7VZVuXCJrMRJxmM78yYevwE4ikq7oKZdiebclbWTOOeikCWhBWcb7ttpTjYhz8_VfK4v1lJ9UUxYpgfOipvounWBc9U6habbaS2dDcIhzOiq6KYJGiHqWXOm0jeY7G4r8rokemF6EokfkkK5iJ-ypp19a3Yo0fWjdRn6_l9I8--AyTULdPoaXo3QkX3JIu_AszDswovZuDi-B8dXaZ84s4NnuVimULfg2Sz_CVywfmAXFJFFwa_3gc3GcEL2HZ-IcvaLN3B5evLj21k5Jkkou6aRyxK_T7zxzmvrKMe5FdRapXmofCNR61HoqXcWcUSsAnG_Rx48Fq2yTknlxFvYGq6H8B6YrrjnhLFkDHXlGsW7KGLnBPc2oN9UwORBZaYbGcQpkcUvg54EvdYkJRtSsklKLuDz6o6bzJ7xn7pfqRdW9Yj3Op3A0WDG0WAeGw0FHGAfonR0rJQkNrm6FolYjDJxFfDpoXcNziNaHLFDuL5bGIRJaMXrtsI673Jvr0QRFVp6xFUFyI1xsCHr5pWh_5m4uomgED3OD0_RuI_wktSVwi3FPmwtb-_CAWx398t-cXsIz-VcHaZpgMfZ75M_29gK8A
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Vision+and+Vision-Related+Measures+in+Progressive+Multiple+Sclerosis&rft.jtitle=Frontiers+in+Neurology&rft.au=Friedemann+Paul&rft.au=Netta+Levin&rft.au=Yael+Backner&rft.au=Dimitrios+Karussis&rft.date=2019-05-03&rft.pub=Frontiers+Media+SA&rft.eissn=1664-2295&rft.volume=10&rft_id=info:doi/10.3389%2Ffneur.2019.00455
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-2295&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-2295&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-2295&client=summon